Evaluation of the immunogenicity of human iPS cell-derived neural stem/progenitor cells in vitro
To achieve the goal of a first-in-human trial for human induced pluripotent stem cell (hiPSC)-based transplantation for the treatment of various diseases, allogeneic human leukocyte antigen (HLA)-matched hiPSC cell banks represent a realistic tool from the perspective of quality control and cost per...
Main Authors: | Masahiro Ozaki, Akio Iwanami, Narihito Nagoshi, Jun Kohyama, Go Itakura, Hiroki Iwai, Soraya Nishimura, Yuichiro Nishiyama, Soya Kawabata, Keiko Sugai, Tsuyoshi Iida, Kohei Matsubayashi, Miho Isoda, Rei Kashiwagi, Yoshiaki Toyama, Morio Matsumoto, Hideyuki Okano, Masaya Nakamura |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-03-01
|
Series: | Stem Cell Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1873506117300077 |
Similar Items
-
Pretreatment with a γ-Secretase Inhibitor Prevents Tumor-like Overgrowth in Human iPSC-Derived Transplants for Spinal Cord Injury
by: Toshiki Okubo, et al.
Published: (2016-10-01) -
Grafted Human iPS Cell-Derived Oligodendrocyte Precursor Cells Contribute to Robust Remyelination of Demyelinated Axons after Spinal Cord Injury
by: Soya Kawabata, et al.
Published: (2016-01-01) -
A review of regenerative therapy for spinal cord injury using human iPS cells
by: Momotaro Kawai, et al.
Published: (2023-03-01) -
Regenerative Medicine for Spinal Cord Injury Using Induced Pluripotent Stem Cells
by: Narihito Nagoshi, et al.
Published: (2024-01-01) -
Hepatocyte growth factor pretreatment boosts functional recovery after spinal cord injury through human iPSC-derived neural stem/progenitor cell transplantation
by: Yu Suematsu, et al.
Published: (2023-10-01)